Mayne Pharma Group Share Price and Company Fundamentals



Price
$0.19
Change
-0.010 (-5.000%)
52 week
0.19 - 0.425

Last traded: Today at 5:10 AM

Mayne Pharma Group Limited, a specialty pharmaceutical company, manufactures and sells branded and generic pharmaceutical products in Australia, New Zealand, the United States, Canada, Europe and Asia. The company operates through four segments: Metrics Contract Services, International, Branded Products, and Portfolio Products. It provides oral drug delivery systems; and contract pharmaceutical development, manufacturing, and analytical services to third-party customers, as well as distributes specialty pharmaceutical products in the dermatology, women's health, and infectious disease therapeutic areas. The company was formerly known as Halcygen Pharmaceuticals Limited and changed its name to Mayne Pharma Group Limited in November 2010. Mayne Pharma Group Limited was incorporated in 2005 and is based in Salisbury South, Australia.

Key Metrics

PE ratio

-

PB ratio

0.71

Dividend yield

0.00%

Beta

1.00

Market cap

-

Enterprise value

-

Company profile

Primary activities Develops, manufactures and markets branded and generic pharmaceutical products globally
Industry / Sector Drug Manufacturers—General / Healthcare
Website https://www.maynepharma.com
Mailing address 1538 Main North Road Salisbury South SA 5106 Australia
Phone / Fax 61 8 8209 2666 / 61 8 8281 0284
Share registry COMPUTERSHARE INVESTOR SERVICES PTY LIMITED

Dividends

More: Mayne Pharma Group Dividend history, yield and payout ratio

Dividend yield

0.00%

Dividend amount

$0.00

Payout ratio

0.00%

Mayne Pharma Group paid $0.00 dividend and the ex-dividend date was 18 Jan 2023.The dividend payout ratio is 0.00%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.MYX dividend payout ratio is less than 70. This is ideal as it gives company room to grow the dividends and also the excess earnings can be invested in company for growth.

MYX's forward dividend amount is $0.04 and the forward dividend yield is 19.00%. A forward dividend yield is the percentage of a company's current stock price that it expects to pay out as dividends over a certain time period, generally 12 months. Forward dividend yields are generally used in circumstances where the yield is predictable based on past instances. If not, trailing yields, which indicate the same value over the previous 12 months, are used.

Company Executives

As of Dec 2022, following are the company executives and directors listed on Mayne Pharma Group.

Name Title Age Total Pay
Mr. Shawn Patrick O'Brien B.Sc CEO, MD & Director
Mr. Aaron Gray Chief Financial Officer
Ms. Lisa Pendlebury VP of Investor Relations & Communications 46 307.58k
Ms. Kimberly Parker J.D. Exec. VP & Gen. Counsel
Mr. Brant Schofield Exec. VP of Corp. Devel. 55 1.04M
Dr. Andrew O. Herdman Ph.D. VP of Group HR
Mr. Stefan J. Cross Pres of International Operations 48 593.18k
Mr. Daniel Moore Exec. VP of Specialty Products & Patient Solutions
Mr. Gerard G. Nahum M.D. Chief Medical Officer
Mr. Hemanshu N. Pandya Sr. VP & Head of Generic Product Division

Profitability and management effectiveness

Profit margin

-61.99%

Operating margin

-17.01%

Return on assets

-3.28%

Return on equity

-41.24%

Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.

The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.

Valuation and Trading Info

The market capitalization of Mayne Pharma Group is and its enterprise value is .

The MYX's stocks Beta value is 1.00 making it 0% less volatile compared to ASX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.

Companies similar to Mayne Pharma Group (MYX)

Mayne Pharma Group (ASX:MYX) Frequently Asked Questions

1. What is Mayne Pharma Group's Stock Symbol?

Mayne Pharma Group trades on ASX under the ticker symbol "MYX".

2. What is Mayne Pharma Group's stock price today?

One share of MYX stock can currently be purchased for approximately $0.19.

3. How can I contact Mayne Pharma Group?

Mayne Pharma Group's mailing address is 1538 Main North Road Salisbury South SA 5106 Australia. The company can be reached via phone at 61 8 8209 2666.

4. What is Mayne Pharma Group's official website?

The official website of Mayne Pharma Group is https://www.maynepharma.com.

5. Which share registry manages Mayne Pharma Group's stock?

Mayne Pharma Group's stock is managed by COMPUTERSHARE INVESTOR SERVICES PTY LIMITED.